CVKD
Cadrenal Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 17, 2026 3:40:14 PM EST
1.86USD+32.857%(+0.46)386,030
Pre-marketNov 17, 2026 9:28:30 AM EST
1.34USD-4.286%(-0.06)
After-hoursNov 17, 2026 4:49:30 PM EST
1.92USD+3.226%(+0.06)
CVKD Financials
In Q3 FY 2026 (ended ), Cadrenal Therapeutics, Inc. Common Stock (CVKD) reported net income of −$1.25M, operating cash flow of −$1.92M, and assets of $3.46M (filed ).
Loading financial flows…